中國奧園(03883.HK)澄清:京漢置業限制消費令已獲撤銷,亦未被列為失信名單
格隆匯11月1日丨中國奧園(03883.HK)發佈公吿,董事會注意到若干媒體報導有關公司間接全資附屬公司京漢置業集團有限責任公司(“京漢置業”)的企業借貸糾紛。該等媒體報導指京漢置業被出具限制消費令及列為失信名單。公司謹此作出該公吿,以澄清該等市場傳聞。
該糾紛發生於2017年,為公司收購京漢置業前產生的歷史糾紛。於2021年9月30日,京漢置業與對方已達成和解協議,目前正在履行中。經作出合理查詢後,京漢置業的限制消費令已獲撤銷,京漢置業亦未被列為失信名單。董事會認為該糾紛對集團的日常營運及業務並無重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.